You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 148 No. 4, April 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of β-Blockers on Mental Performance on Older Hypertensive Patients

Fran M. Gengo, PharmD; Susan C. Fagan, PharmD; Anthony de Padova, MD; J. Keith Miller, MD; Peter R. Kinkel, MD

Arch Intern Med. 1988;148(4):779-784.


Abstract

• This double-blind, three-way crossover study measured the influence of β-blocker treatment on drowsiness and mental test performance in older hypertensive patients and determined if lipophilicity was a determinant of these effects. Twenty-seven hypertensive patients (mean age, 63±3 years) were studied. Patients received two weeks each of daily treatment with placebo, 100 mg of atenolol, or 150 mg of metoprolol tartrate and were evaluated on the 14th day of each treatment period, after which their next treatment period began. Mental performance was measured using Trails-A maze testing. Drowsiness was measured subjectively using a visual analogue scale, and objectively using critical fusion-frequency threshold testing. Blood pressure control was equivalent and clinically adequate in all subjects. Steady-state levels of metoprolol tartrate (235±46 ng/mL) and atenolol (453.6±56 ng/nL) achieved were those expected to produce similar β-blockade. Mental performance as measured by Trials-A testing showed better scores during β-blocker treatment compared with placebo. Trails-A scores improved as patients went from placebo to metoprolol treatment, but did not change as patients went from placebo to atenolol treatment. Critical fusion-frequency threshold measurements were lower following administration of both drugs than following that of placebo, but subjectively there was no difference in feelings of lethargy between either β-blocker and placebo. These data show greater improvement in mental testing performance to be associated with metoprolol treatment, but neither produced more lethargy than placebo in elderly patients.

(Arch Intern Med 1988;148:779-784)



Author Affiliations

From the Dent Neurologic Institute (Drs Gengo, Fagan, Miller, and Kinkel), and the Department of Neurology, School of Medicine (Drs Gengo, Fagan, and Kinkel) and the Department of Pharmacy and Pharmaceutics, School of Pharmacy (Dr Gengo), State University of New York at Buffalo; and the Morristown (NJ) Memorial Hospital and Ciba-Geigy Pharmaceuticals, Summit, NJ (Dr de Padova).


Footnotes

Accepted for publication Dec 3, 1987.

Presented at the Second International Cardiovascular Pharmacology Meeting, San Francisco, Oct 19, 1987.

Reprint requests to Neuropharmacology Division, Dent Neurologic Institute, 3 Gates Circle, Buffalo, NY 14209 (Dr Gengo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Commentary
Lowenthal
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M664-665.
FULL TEXT  

Propranolol Treatment of Chronically Hospitalized Aggressive Patients
Silver et al.
J. Neuropsychiatry Clin. Neurosi. 1999;11:328-335.
ABSTRACT | FULL TEXT  

Impact of the Treatment of Isolated Systolic Hypertension on Behavioral Variables: Results From the Systolic Hypertension in the Elderly Program
Applegate et al.
Arch Intern Med 1994;154:2154-2160.
ABSTRACT  

Atenolol Compared with Nifedipine: Effect on Cognitive Function and Mood in Elderly Hypertensive Patients
Skinner et al.
ANN INTERN MED 1992;116:615-623.
ABSTRACT  

Reflections on the Impact of Antihypertensive Medications on Mood, Sedation, and Neuropsychologic Functioning
Dimsdale
Arch Intern Med 1992;152:35-39.
ABSTRACT  

Effect of Antihypertensives on Sexual Function and Quality of Life: The TAIM Study
Wassertheil-Smoller et al.
ANN INTERN MED 1991;114:613-620.
ABSTRACT  

Long-term Cost-effectiveness of Various Initial Monotherapies for Mild to Moderate Hypertension
Edelson et al.
JAMA 1990;263:407-413.
ABSTRACT  

Hypertension in Elderly Patients
Applegate
ANN INTERN MED 1989;110:901-915.
ABSTRACT  

{beta}-Blockers and Cognitive Performance in Older Patients
MINTZER
Arch Intern Med 1989;149:1223-1224.
ABSTRACT  

Neuropsychological Side Effects of {beta}-Blockers
Dimsdale and Newton
Arch Intern Med 1989;149:514-525.
ABSTRACT  

{beta}-Blockade and Mental Performance-Reply
GENGO
Arch Intern Med 1989;149:473-475.
ABSTRACT  

{beta}-Blockade and Mental Performance
OLINER and MURPHY
Arch Intern Med 1989;149:475-475.
ABSTRACT  

Mental Testing With Metoprolol
MURCHISON
Arch Intern Med 1989;149:472-475.
ABSTRACT  

{beta}-Blockers and Mental Performance
Frohlich
Arch Intern Med 1988;148:777-778.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.